2021
DOI: 10.1038/s41422-020-00464-8
|View full text |Cite
|
Sign up to set email alerts
|

Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury

Abstract: Compelling evidence has revealed that biased activation of G protein-coupled receptor (GPCR) signaling, including angiotensin II (AngII) receptor type 1 (AT1) signaling, plays pivotal roles in vascular homeostasis and injury, but whether a clinically relevant endogenous biased antagonism of AT1 signaling exists under physiological and pathophysiological conditions has not been clearly elucidated. Here, we show that an extracellular matrix protein, cartilage oligomeric matrix protein (COMP), acts as an endogeno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
27
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 82 publications
(119 reference statements)
2
27
0
Order By: Relevance
“…Yi Fu et al found that it could act as an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury. Its de ciency aggravated AngII-induced AAA formation [51]. Thrombospondin-1 (Thbs1) also is a matricellular protein involved in the maintenance of vascular structure and homeostasis through the regulation of cell proliferation, apoptosis, and adhesion.…”
Section: Discussionmentioning
confidence: 99%
“…Yi Fu et al found that it could act as an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury. Its de ciency aggravated AngII-induced AAA formation [51]. Thrombospondin-1 (Thbs1) also is a matricellular protein involved in the maintenance of vascular structure and homeostasis through the regulation of cell proliferation, apoptosis, and adhesion.…”
Section: Discussionmentioning
confidence: 99%
“…COMP is identified as an endogenous allosteric deviation modulator of angiotensin II type 1 (AT1) receptor. COMP deficiency activates the AT1 receptor/β-arrestin-2 signal ( Figure 6 ), which exacerbates the activation of AT1 receptor-related diseases, such as abdominal aortic aneurysm [ 27 ]. Aortic aneurysm in COMP −/− mice could be rescued by the application of a peptidomimetic that mimics the AT1-binding motif of COMP [ 27 ].…”
Section: Comp and Cardiovascular Diseasementioning
confidence: 99%
“…COMP deficiency activates the AT1 receptor/β-arrestin-2 signal ( Figure 6 ), which exacerbates the activation of AT1 receptor-related diseases, such as abdominal aortic aneurysm [ 27 ]. Aortic aneurysm in COMP −/− mice could be rescued by the application of a peptidomimetic that mimics the AT1-binding motif of COMP [ 27 ]. Human studies also show that COMP downregulation is associated with aortic aneurysm [ 114 ].…”
Section: Comp and Cardiovascular Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…Although compelling evidence indicates that biased activation of G protein-coupled receptor (GPCR) signalling, like AT 1 R signalling, plays a role in vascular homeostasis and injury, it is unclear whether clinically relevant endogenous-biased antagonism of AT 1 R signalling exists in physiological and pathophysiological circumstances. Explorations of the endogenous-biased antagonism of AT 1 R or other GPCRs may provide innovative treatment options for cardiovascular disorders [ 64 ].…”
Section: The Renal View Of Conventional Ras In Aki Induced By Ririmentioning
confidence: 99%